Functionalized Superparamagnetic Iron Oxide Nanoparticles (SPIONs) as Platform for the Targeted Multimodal Tumor Therapy

Frontiers in Oncology
Christina JankoChristoph Alexiou

Abstract

Standard cancer treatments involve surgery, radiotherapy, chemotherapy, and immunotherapy. In clinical practice, the respective drugs are applied orally or intravenously leading to their systemic circulation in the whole organism. For chemotherapeutics or immune modulatory agents, severe side effects such as immune depression or autoimmunity can occur. At the same time the intratumoral drug doses are often too low for effective cancer therapy. Since monotherapies frequently cannot cure cancer, due to their synergistic effects multimodal therapy concepts are applied to enhance treatment efficacy. The targeted delivery of drugs to the tumor by employment of functionalized nanoparticles might be a promising solution to overcome these challenges. For multimodal therapy concepts and individualized patient care nanoparticle platforms can be functionalized with compounds from various therapeutic classes (e.g. radiosensitizers, phototoxic drugs, chemotherapeutics, immune modulators). Superparamagnetic iron oxide nanoparticles (SPIONs) as drug transporters can add further functionalities, such as guidance or heating by external magnetic fields (Magnetic Drug Targeting or Magnetic Hyperthermia), and imaging-controlled therapy (Magnetic R...Continue Reading

References

Jan 1, 1978·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·H BassW T Coakley
Jun 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L W KwakS J Horning
Oct 1, 1986·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·M Quintiliani
Mar 22, 1996·Science·D R LeachJ P Allison
Feb 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y OheY Nishiwaki
Jun 30, 2001·The New England Journal of Medicine·C L Shapiro, A Recht
Jul 6, 2002·Critical Reviews in Oncology/hematology·Bert HildebrandtHanno Riess
Jun 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mala ChakrabortyJames W Hodge
Jul 16, 2004·Seminars in Radiation Oncology·Peter Vaupel
Sep 25, 2007·Nature Biotechnology·Hak Soo ChoiJohn V Frangioni
Mar 15, 2008·Cancer Research·Chitta Ranjan PatraDebabrata Mukhopadhyay
Jun 20, 2008·Advanced Drug Delivery Reviews·Misara HamoudehHatem Fessi
Oct 9, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Minghuang HongYuanying Pei
Dec 2, 2009·Methods in Molecular Biology·Jean-Pierre Gillet, Michael M Gottesman
Oct 20, 2010·International Journal of Nanomedicine·Emily S DayJennifer L West
Nov 23, 2010·International Journal of Pharmaceutics·Caixia FanZhiliang Chen
Jun 15, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·You Han Bae, Kinam Park
Jul 19, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Beata ChertokVictor C Yang
Sep 29, 2011·The Cancer Journal·Teofila SeremetPierre G Coulie
Jan 1, 2010·Nano Reviews·Neenu SinghShareen H Doak
Jan 24, 2012·Drug Design, Development and Therapy·Sapna P Patel, Scott E Woodman
Apr 17, 2012·Therapeutic Delivery·Dev Kumar ChatterjeeSunil Krishnan
Jul 31, 2012·Biochemical and Biophysical Research Communications·Stefanie KleinCarola Kryschi
Oct 20, 2012·International Journal of Radiation Oncology, Biology, Physics·Silvia C Formenti, Sandra Demaria
Nov 20, 2012·Annual Review of Immunology·Guido KroemerLaurence Zitvogel
Feb 9, 2013·Cytokine & Growth Factor Reviews·Aleksandra M DudekPatrizia Agostinis
Apr 4, 2013·International Journal of Molecular Sciences·Christina JankoChristoph Alexiou
May 15, 2013·Nanomedicine : Nanotechnology, Biology, and Medicine·Rainer TietzeChristoph Alexiou
Oct 3, 2013·Current Medicinal Chemistry·M SirovaB Rihova
May 16, 2014·The Journal of Physical Chemistry. B·Stefanie KleinCarola Kryschi
May 31, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Charlene M DawidczykPeter C Searson
Jul 10, 2014·Journal of Cancer Research and Clinical Oncology·Remon BazakTamer Refaat
Nov 5, 2014·International Journal of Nanomedicine·Jan ZalogaChristoph Alexiou
Dec 4, 2014·ACS Nano·Kun ShaoPere Santamaria
Jan 22, 2015·Arthritis Research & Therapy·Sabrina CeerazRandolph J Noelle
Mar 26, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Gwen WyattGordan Srkalovic

❮ Previous
Next ❯

Citations

Feb 9, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ana-Maria PutzCristina Dehelean
Nov 7, 2019·Nanomaterials·Ioana-Andreea Turin-MoleavinMariana Pinteala
Aug 21, 2019·Anti-cancer Agents in Medicinal Chemistry·Paromita KunduSanjeeb K Sahoo
Apr 8, 2021·Emerging Topics in Life Sciences·Yogita Patil-Sen
May 31, 2021·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Mohammad Afsar KhanHifzur R Siddique

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.